Developments on the Frontier of Transcatheter Aortic Valve Replacement (TAVR) Devices
Reporter: Aviva Lev-Ari, PhD, RN
UPDATED on 4/28/2016
Recent TAVR approvals prompt changes to Direct Flow’s Salus trial
acWire for Precise Transcatheter Aortic Valve Replacement Gets FDA Green Light (VIDEO)
by EDITORS on Jan 14, 2014 • 1:58 pm
MediValve, a company based in Kibbutz HaMa’apil, Israel, just received 510(k) clearance from the FDA to bring to the U.S. its acWire guidewire. The device is primarily designed to position transcatheter prosthetic heart valves with greater precision than many current delivery systems allow.
The advantage of the acWire is that once its active components are moved past the diseased valve, it’s opened up like a flower and drawn back to the valve, aligning itself snugly just past the valve opening. Three radiopaque markers on the petals help the physician visualize how the device is positioned before placing the valve.
Here’s a quick animation that demonstrates the functionality of acWire:
VIEW VIDEO
Product page: acWire…
SOURCE
Leave a Reply